| Bioactivity | Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro[1][2]. |
| Invitro | Apolizumab can induce ADCC and CMC based on expression of target antigen[2]. Apolizumab alter cell membrane polarization and permeability but may not induce apoptosis directly[2]. |
| Name | Apolizumab |
| CAS | 267227-08-7 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |